This inventor holds 1 USPTO granted patent and 2 published patent applications. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Years Active: 2024
Title: Sergey Anatolevich Shmakov: Innovator in Biotechnology
Introduction
Sergey Anatolevich Shmakov is a notable inventor based in Voskresensk, Russia. He has made significant contributions to the fields of biotechnology, molecular biology, and medicine. His work primarily focuses on nuclease enzymes, which play a crucial role in genetic engineering and therapeutic applications.
Latest Patents
One of Shmakov's key inventions is the PaCas9 nuclease. This patent relates to a nuclease enzyme and its various applications. The invention encompasses a nucleic acid encoding the nuclease, a genetic construct, an expression vector, and a delivery vector that includes the nucleic acid. Additionally, it involves a liposome containing the nuclease or the nucleic acid encoding the nuclease, methods for producing the nuclease, and methods for delivery. The patent highlights the potential of the PaCas9 nuclease in advancing biotechnological applications.
Career Highlights
Throughout his career, Sergey Shmakov has focused on innovative solutions in biotechnology. His work has led to advancements in the understanding and application of nuclease enzymes. With a patent portfolio that includes 1 patent, he has established himself as a key figure in his field.
Collaborations
Shmakov has collaborated with notable colleagues, including Dmitrii Aleksandrovich Sutormin and Tatyana Igorevna Zyubko. These collaborations have contributed to the development and refinement of his inventions, enhancing their applicability in various scientific domains.
Conclusion
Sergey Anatolevich Shmakov is a prominent inventor whose work in biotechnology, particularly with the PaCas9 nuclease, showcases his innovative spirit and dedication to advancing science. His contributions are paving the way for future developments in molecular biology and medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile